Clinical Trials

Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -

Condition:   Osseous Paget's Disease
Intervention:   Drug: Sodium risedronate
Sponsor:   Takeda
Completed

Tue, 08 Apr 2014 12:00:00 EDT

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

Condition:   Osteoporosis
Interventions:   Drug: Actonel®;   Drug: Denosumab
Sponsor:   Amgen
Completed

Fri, 12 Jun 2009 12:00:00 EDT

Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: risedronate;   Drug: Placebo risedronate oral tablet
Sponsors:   UConn Health;   Proctor and Gamble/Aventis
Completed

Tue, 10 Mar 2009 12:00:00 EDT

A Study of Actonel for the Prevention of Bone Loss

Conditions:   Leukemia;   Lymphoma
Interventions:   Drug: Actonel (Risedronate);   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
Sponsors:   M.D. Anderson Cancer Center;   Procter and Gamble
Completed

Tue, 27 Mar 2007 12:00:00 EDT

Prophylactic Riserodrenate for Patients With Peripheral Lung Tumors Treated With SBRT

Condition:   Lung Neoplasm
Interventions:   Drug: risedronate;   Drug: Matching placebo
Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI)
Recruiting

Mon, 04 Mar 2019 12:00:00 EST

Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid Therapy

Condition:   Osteoporosis
Intervention:   Drug: Actonel
Sponsor:   Sanofi
Completed

Fri, 15 Feb 2008 12:00:00 EST

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: risedronate;   Drug: Control
Sponsors:   CMX Research;   Sanofi
Completed

Thu, 25 Jan 2007 12:00:00 EST

Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty

Conditions:   Osteoporotic Fractures;   Femoral Neck Fracture
Intervention:   Drug: Risedronate
Sponsor:   Mahidol University
Unknown status

Wed, 28 May 2014 12:00:00 EDT

Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.

Condition:   Renal Transplant Osteodystrophy
Interventions:   Drug: Risedronate;   Drug: Placebo
Sponsor:   Montefiore Medical Center
Completed

Mon, 19 Dec 2005 12:00:00 EST

Effect of Stopping Risedronate After Long Term Treatment on Bone Turnover

Condition:   Postmenopausal Women With Osteoporosis
Interventions:   Drug: Risedronate;   Drug: Placebo/Risedronate
Sponsor:   Warner Chilcott
Completed

Mon, 29 Nov 2010 12:00:00 EST

Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis

Condition:   Osteoporosis
Interventions:   Drug: Risedronate/Cholecalciferol combination;   Drug: Risedronate
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Wed, 29 Aug 2012 12:00:00 EDT

Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use

Condition:   Osteoporosis
Interventions:   Drug: Risedronate;   Drug: Parathyroid Hormone
Sponsors:   University of California, Davis;   University of California, San Francisco
Completed

Thu, 22 Sep 2005 12:00:00 EDT

A Study of Monthly Risedronate for Osteoporosis

Condition:   Postmenopausal Osteoporosis
Intervention:   Drug: risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Tue, 01 Nov 2005 12:00:00 EST

Safety and Efficacy of Risedronate in the Treatment of Osteogenesis Imperfecta in Children

Condition:   Osteogenesis Imperfecta
Interventions:   Drug: risedronate sodium (Actonel);   Drug: Placebo
Sponsor:   Warner Chilcott
Completed

Mon, 21 Mar 2005 12:00:00 EST

Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal Women

Conditions:   Osteoporosis;   Osteopenia
Intervention:   Dietary Supplement: Genistein vs Risedronate
Sponsors:   Purdue University;   National Center for Complementary and Integrative Health (NCCIH);   Office of Dietary Supplements (ODS)
Completed

Thu, 27 Oct 2005 12:00:00 EDT

Effect of Actonel on Periodontal Health of Postmenopausal Women

Condition:   Periodontal Disease
Intervention:   Drug: Risedronate
Sponsor:   University Hospitals Cleveland Medical Center
Unknown status

Tue, 15 Jan 2008 12:00:00 EST

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

Conditions:   Bone Loss;   Osteoporosis;   Breast Cancer
Intervention:   Drug: risedronate
Sponsors:   Susan L. Greenspan;   University of Pittsburgh
Completed

Wed, 13 Jun 2007 12:00:00 EDT

36-month Special Drug Use Surveillance on Frequency of Bone Fractures With Sodium Risedronate 75 mg Tablets

Condition:   Osteoporosis
Intervention:   Drug: Sodium risedronate
Sponsor:   Takeda
Completed

Tue, 08 Apr 2014 12:00:00 EDT

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

Condition:   Other Osteoporosis
Interventions:   Drug: Placebo tablet;   Drug: Risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Thu, 21 Feb 2008 12:00:00 EST

Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

Condition:   Osteoporosis
Intervention:   Drug: risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Thu, 05 Feb 2009 12:00:00 EST

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

Condition:   Osteoporosis
Intervention:   Drug: Sodium Risedronate
Sponsor:   Takeda
Completed

Tue, 18 Mar 2014 12:00:00 EDT

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Condition:   Postmenopausal Osteoporosis
Intervention:   Drug: risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Thu, 20 Dec 2007 12:00:00 EST

Combination Risedronate - Parathyroid Hormone Trial in Male Osteoporosis

Condition:   Osteoporosis
Interventions:   Drug: Risedronate;   Drug: Teriparatide;   Drug: Placebo Teriparatide;   Drug: placebo Risedronate
Sponsors:   Columbia University;   Alliance for Better Bone Health
Completed

Tue, 05 Jun 2012 12:00:00 EDT

Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced Osteoporosis

Condition:   Osteoporosis
Interventions:   Drug: Teriparatide;   Drug: Risedronate
Sponsor:   Eli Lilly and Company
Completed

Wed, 18 Jul 2007 12:00:00 EDT

Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty

Condition:   Bone Loss
Interventions:   Drug: Risedronate;   Drug: Placebo
Sponsors:   Danderyd Hospital;   Sanofi
Completed

Wed, 15 Oct 2008 12:00:00 EDT

Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis

Condition:   Prosthesis Loosening
Interventions:   Drug: risedronate;   Drug: placebo
Sponsor:   University Hospital, Limoges
Terminated

Wed, 20 Apr 2016 12:00:00 EDT

Bisphosphonate Use to Mitigate Bone Loss

Condition:   Bone Loss
Interventions:   Drug: Risedronate;   Drug: Placebo
Sponsor:   Wake Forest University Health Sciences
Not yet recruiting

Thu, 10 Jun 2021 12:00:00 EDT

Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects

Condition:   Osteoporosis
Intervention:   Drug: Risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Wed, 18 Jun 2008 12:00:00 EDT

Effects of Bisphosphonates on OI-Related Hearing Loss

Condition:   Osteogenesis Imperfecta
Intervention:   Drug: Risedronate Oral Tablet
Sponsors:   Hospital for Special Surgery, New York;   The New York Community Trust;   Weill Medical College of Cornell University;   Northwell Health
Recruiting

Tue, 05 Nov 2019 12:00:00 EST

Heartland Osteoporosis Prevention Study

Condition:   Osteopenia
Interventions:   Drug: Calcium Carbonate;   Drug: Vitamin D3;   Drug: Risedronate;   Behavioral: Bone-loading exercises
Sponsors:   Nancy L. Waltman, BSN MSN PhD;   Creighton University Medical Center;   University of Nebraska
Unknown status

Thu, 10 Jul 2014 12:00:00 EDT

Prevention of Osteoporosis in Breast Cancer Survivors

Condition:   Postmenopausal Osteoporosis
Intervention:   Other: risedronate, calcium/vit D, strength weight training
Sponsor:   University of Nebraska
Completed

Wed, 05 Dec 2007 12:00:00 EST

ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a Week

Condition:   Osteoporosis
Intervention:   Drug: Risedronate
Sponsors:   Sanofi;   Procter and Gamble
Terminated

Tue, 16 Oct 2007 12:00:00 EDT

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

Condition:   Osteoporosis
Intervention:   Drug: risedronate (including placebo)
Sponsors:   University of Pittsburgh;   Procter and Gamble;   Aventis Pharmaceuticals
Completed

Mon, 11 Jul 2005 12:00:00 EDT

A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: Risedronate Sodium
Sponsor:   Sanofi
Completed

Mon, 10 Mar 2008 12:00:00 EDT

Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease

Conditions:   Crohn's Disease;   Low Bone Mineral Density
Interventions:   Drug: risedronate;   Drug: placebo
Sponsor:   University of Alberta
Completed

Thu, 07 Oct 2010 12:00:00 EDT

Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis

Conditions:   Osteoporosis, Postmenopausal;   Back Pain;   Spinal Fracture
Interventions:   Drug: teriparatide;   Drug: risedronate;   Drug: placebo
Sponsor:   Eli Lilly and Company
Completed

Thu, 22 Jun 2006 12:00:00 EDT

Weight Loss With Risedronate for Bone Health

Conditions:   Bariatric Surgery Candidate;   Bone Loss;   Weight Loss
Interventions:   Drug: Risedronate Sodium 150 MG;   Other: Placebo
Sponsors:   Wake Forest University Health Sciences;   Wake Forest University
Completed

Fri, 26 Jan 2018 12:00:00 EST

Risedronate in Osteopenic Postmenopausal Women

Condition:   Osteoporosis
Interventions:   Drug: risedronate;   Drug: risedronate placebo
Sponsors:   Sanofi;   Procter and Gamble
Completed

Wed, 28 Jun 2006 12:00:00 EDT

Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer

Conditions:   Breast Cancer;   Menopause;   Osteopenia
Interventions:   Drug: Risedronate;   Drug: Placebo
Sponsor:   Hospices Civils de Lyon
Completed

Wed, 11 Mar 2009 12:00:00 EDT

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Condition:   Metastatic Prostate Cancer
Interventions:   Drug: Risedronate;   Drug: Placebo
Sponsors:   Christopher Sweeney, MBBS;   Sanofi;   Walther Cancer Institute;   Hoosier Cancer Research Network
Terminated

Thu, 22 Sep 2005 12:00:00 EDT

IGF-1 and Bone Loss in Women With Anorexia Nervosa

Conditions:   Anorexia Nervosa;   Osteopenia;   Osteoporosis
Interventions:   Drug: rhIGF-1;   Drug: Risedronate;   Drug: Placebo
Sponsor:   Massachusetts General Hospital
Completed

Mon, 01 Aug 2011 12:00:00 EDT

IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)

Condition:   Osteoporosis
Intervention:   Drug: risedronate
Sponsors:   Sanofi;   Procter and Gamble
Completed

Thu, 22 Dec 2005 12:00:00 EST

Risedronate Sodium in Post Menopausal Osteoporosis

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: risedronate sodium
Sponsors:   Sanofi;   Procter and Gamble
Completed

Thu, 29 Mar 2007 12:00:00 EDT

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Condition:   Postmenopausal Osteoporosis
Intervention:   Drug: risedronate
Sponsor:   Warner Chilcott
Completed

Wed, 10 Oct 2007 12:00:00 EDT

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

Condition:   Osteoporosis
Interventions:   Drug: Risedronate/Cholecalciferol combination(montly);   Drug: Risedronate/Cholecalciferol combination(weekly)
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Mon, 22 Jul 2013 12:00:00 EDT

Study of the Effect of Once a Week Risedronate on the Microstructure of Tibia and Radius Using a New Scanning Method

Condition:   Osteopenia
Interventions:   Drug: Placebo comparator;   Drug: risedronate
Sponsor:   Warner Chilcott
Completed

Wed, 11 Oct 2006 12:00:00 EDT

A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects

Condition:   Osteoporosis
Interventions:   Drug: risedronate DR (Phase III clinical supply);   Drug: risedronate 35 mg DR (Commercial Tablet)
Sponsors:   Warner Chilcott;   Sanofi
Completed

Wed, 18 Feb 2009 12:00:00 EST

Study Assessing Dosing Time and Calcium and Vitamin D on the Relative BA of 35 mg DR Risedronate Dosed With Food

Condition:   Healthy
Intervention:   Drug: 35 mg risedronate DR tablet
Sponsors:   Warner Chilcott;   Sanofi
Completed

Wed, 25 Mar 2009 12:00:00 EDT

Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose

Conditions:   Osteopenia;   Osteoporosis
Interventions:   Drug: risedronate;   Drug: alendronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Thu, 20 Dec 2007 12:00:00 EST

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Condition:   Paget's Disease of Bone
Interventions:   Drug: Zoledronic Acid;   Drug: Risedronate;   Drug: Placebo to Risedronate;   Drug: Placebo to Zoledronic Acid;   Dietary Supplement: Calcium and Vitamin D
Sponsor:   Novartis Pharmaceuticals
Completed

Wed, 15 Jan 2003 12:00:00 EST

Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury

Condition:   Osteoporosis
Intervention:   Drug: Risedronate
Sponsors:   Toronto Rehabilitation Institute;   The Physicians' Services Incorporated Foundation;   St. Joseph's Health Care London
Completed

Tue, 30 Aug 2005 12:00:00 EDT

Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer

Condition:   Breast Cancer
Interventions:   Drug: Anastrozole;   Drug: Risedronate Sodium
Sponsor:   AstraZeneca
Completed

Thu, 06 May 2004 12:00:00 EDT

Risedronate in Postmenopausal Women With Low Bone Density

Condition:   OSTEOPOROSIS, POSTMENOPAUSAL
Intervention:   Drug: RISEDRONATE
Sponsors:   Sanofi;   Procter and Gamble
Completed

Wed, 12 Jul 2006 12:00:00 EDT

POWER Point of Care Effect on Satisfaction of Treatment

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: Risedronate Sodium (Actonel)
Sponsors:   Sanofi;   Procter and Gamble
Completed

Thu, 25 Oct 2007 12:00:00 EDT

A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 Tablets

Condition:   Involutional Osteoporosis
Interventions:   Drug: NE-58095 IR;   Drug: NE-58095 IR Placebo;   Drug: NE-58095 DR;   Drug: NE-58095 DR Placebo
Sponsors:   Takeda;   EA Pharma Co., Ltd.
Completed

Fri, 14 Feb 2014 12:00:00 EST

Risedronate in the Prevention of Osteoporosis in Postmenopausal Women

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: Risedronate (HMR4003)
Sponsors:   Sanofi;   Procter and Gamble
Completed

Wed, 22 Nov 2006 12:00:00 EST

Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: risedronate (HMR4003)
Sponsors:   Sanofi;   Procter and Gamble
Completed

Mon, 17 Jul 2006 12:00:00 EDT

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: risedronate sodium
Sponsors:   Sanofi;   Procter and Gamble
Completed

Mon, 15 Aug 2005 12:00:00 EDT

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Condition:   Osteoporosis Postmenopausal
Intervention:   Drug: Risedronate (HMR4003)
Sponsors:   Sanofi;   Procter and Gamble
Completed

Mon, 31 Jul 2006 12:00:00 EDT

Food Effects on the Relative Bioavailability of Different Dosages of Risedronate

Conditions:   Postmenopausal;   Non-lactating;   Surgically Sterile
Intervention:   Drug: risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Wed, 16 Jul 2008 12:00:00 EDT

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Conditions:   Breast Cancer;   Osteoporosis
Interventions:   Dietary Supplement: calcium carbonate;   Dietary Supplement: vitamin D;   Drug: risedronate sodium;   Other: placebo
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
Completed

Thu, 06 Feb 2003 12:00:00 EST

Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate

Condition:   Bioavailability
Intervention:   Drug: Risedronate
Sponsors:   Warner Chilcott;   Sanofi
Completed

Fri, 19 Sep 2008 12:00:00 EDT

Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate

Condition:   Postmenopausal Women
Intervention:   Drug: risedronate
Sponsor:   Warner Chilcott
Completed

Thu, 20 Dec 2007 12:00:00 EST

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Condition:   Post-menopausal Osteoporosis
Interventions:   Drug: Ibandronate;   Drug: Risedronate;   Drug: Alendronate
Sponsors:   Sheffield Teaching Hospitals NHS Foundation Trust;   Procter and Gamble;   University of Sheffield
Completed

Fri, 25 Apr 2008 12:00:00 EDT

Antiepileptic Drugs and Osteoporotic Prevention Trial

Conditions:   Epilepsy;   Bone Loss;   Osteoporosis;   Fractures
Interventions:   Drug: Risedronate;   Drug: Placebo + Calcium and Vitamin D
Sponsors:   Boston VA Research Institute, Inc.;   Procter and Gamble;   Alliance for Better Bone Health;   VA Boston Healthcare System
Completed

Thu, 26 Mar 2009 12:00:00 EDT

Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD

Condition:   Postmenopausal
Interventions:   Drug: risedronate;   Drug: experimental
Sponsors:   Warner Chilcott;   Sanofi
Completed

Thu, 20 Dec 2007 12:00:00 EST

Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone

Condition:   Fibrous Dysplasia of Bone
Interventions:   Drug: risedronate;   Drug: placebo
Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   ZonMw: The Netherlands Organisation for Health Research and Development;   Cliniques universitaires Saint-Luc- Université Catholique de Louvain;   Charite University, Berlin, Germany
Completed

Fri, 09 Mar 2007 12:00:00 EST

SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.

Condition:   Colles' Fracture
Interventions:   Drug: Risedronate sodium;   Drug: Calcium & Vitamine D3
Sponsors:   Sanofi;   Procter and Gamble
Completed

Mon, 16 Apr 2007 12:00:00 EDT

Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation

Condition:   Osteoporosis, Postmenopausal
Interventions:   Drug: Risedronate;   Drug: Raloxifene;   Other: Placebo
Sponsor:   Sanofi
Terminated

Thu, 13 Nov 2008 12:00:00 EST

Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

Condition:   Steroid-induced Osteopor, Glucocorticoid-induced Ostepor
Interventions:   Drug: Denosumab;   Drug: Placebo for risendronate;   Drug: Risendronate;   Drug: Placebo for denosumab
Sponsor:   Amgen
Completed

Thu, 12 Apr 2012 12:00:00 EDT

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

Condition:   Post Menopausal Osteoporosis
Interventions:   Drug: Risedronate;   Drug: ibandronate [Bonviva/Boniva]
Sponsor:   Hoffmann-La Roche
Completed

Mon, 18 Sep 2006 12:00:00 EDT

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)

Condition:   Postmenopausal Osteoporosis
Interventions:   Drug: Alendronate;   Drug: Risedronate 35 mg;   Dietary Supplement: Elemental Calcium;   Dietary Supplement: Vitamin D;   Drug: Risendronate placebo;   Drug: Alendronate placebo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Fri, 24 Sep 2004 12:00:00 EDT

Bone Loss in Women With Anorexia Nervosa

Condition:   Anorexia Nervosa
Interventions:   Drug: Testosterone;   Drug: Actonel (risedronate);   Drug: Placebo Actonel (risedronate);   Drug: Placebo testosterone
Sponsors:   Massachusetts General Hospital;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Center for Research Resources (NCRR)
Completed

Tue, 17 Aug 2004 12:00:00 EDT

Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation Period

Condition:   Paget's Disease of Bone
Interventions:   Drug: zoledronic acid;   Drug: placebo to zoledronic acid;   Drug: Risedronate;   Drug: Placebo to risedronate;   Drug: Calcium and vitamin D supplements
Sponsor:   Novartis Pharmaceuticals
Completed

Tue, 15 Feb 2005 12:00:00 EST

Post-menopausal Women Osteoporosis(Phase III)

Condition:   Postmenopausal Women Osteoporosis
Interventions:   Drug: risedronate combine;   Drug: Risedronate;   Drug: Placebo(for Risedronate);   Drug: Placebo(for risedronate combine)
Sponsor:   Hanlim Pharm. Co., Ltd.
Completed

Thu, 07 Mar 2013 12:00:00 EST

Bone Microarchitecture in Osteopenic Postmenopausal Women

Condition:   Osteoporosis
Interventions:   Drug: placebo;   Drug: risedronate
Sponsors:   Warner Chilcott;   Sanofi
Terminated

Thu, 20 Dec 2007 12:00:00 EST

Replication of the VERO Osteoporosis Trial in Healthcare Claims Data

Condition:   Osteoporosis
Interventions:   Drug: Teriparatide;   Drug: Risedronate
Sponsor:   Brigham and Women's Hospital
Active, not recruiting

Mon, 10 May 2021 12:00:00 EDT

Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)

Condition:   Osteoporosis
Interventions:   Drug: Parathyroid Hormone (PTH);   Drug: Risedronate
Sponsor:   Takeda
Completed

Thu, 17 Aug 2006 12:00:00 EDT

Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?

Condition:   Osteogenesis Imperfecta
Interventions:   Drug: Risedronate Sodium;   Dietary Supplement: Calcichew tablets
Sponsor:   Sheffield Children's NHS Foundation Trust
Completed

Wed, 05 Jul 2017 12:00:00 EDT

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Conditions:   Breast Cancer;   Osteoporosis
Interventions:   Drug: risedronate sodium;   Other: diagnostic laboratory biomarker analysis
Sponsor:   International Breast Cancer Study Group
Withdrawn

Thu, 11 May 2006 12:00:00 EDT

VERtebral Fracture Treatment Comparisons in Osteoporotic Women

Condition:   Postmenopausal Osteoporosis
Interventions:   Drug: Teriparatide;   Drug: Risedronate;   Drug: Placebo;   Drug: Calcium;   Drug: Vitamin D
Sponsor:   Eli Lilly and Company
Completed

Wed, 17 Oct 2012 12:00:00 EDT

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

Condition:   Osteoporosis
Interventions:   Drug: Teriparatide;   Drug: Risedronate;   Drug: Placebo;   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
Sponsor:   Eli Lilly and Company
Completed

Fri, 24 Apr 2009 12:00:00 EDT

Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women

Condition:   Postmenopausal Osteoporosis
Interventions:   Drug: 150 mg;   Drug: 75 mg;   Drug: 100 mg
Sponsor:   Warner Chilcott
Completed

Thu, 11 Jun 2009 12:00:00 EDT

Effects of Bisphosphonates and Nutritional Supplementation After a Hip Fracture

Condition:   Hip Fracture
Interventions:   Drug: Risedronate;   Other: Nutritional supplement;   Dietary Supplement: Calcium and vitamin D3
Sponsor:   Karolinska Institutet
Completed

Wed, 25 Sep 2013 12:00:00 EDT

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

Condition:   Osteoporosis, Postmenopausal
Interventions:   Drug: MK0217, alendronate sodium/Duration of Intervention: 12 mo;   Drug: Comparator: risedronate / Duration of Intervention: 12 mo
Sponsor:   Merck Sharp & Dohme Corp.
Completed

Fri, 24 Sep 2004 12:00:00 EDT

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

Condition:   Postmenopausal Osteoporosis
Intervention:  
Sponsors:   Warner Chilcott;   Sanofi
Completed

Thu, 23 Oct 2008 12:00:00 EDT

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Conditions:   Osteoporosis;   Prostate Cancer
Interventions:   Dietary Supplement: calcium carbonate;   Dietary Supplement: cholecalciferol;   Drug: Estrogen Antagonists;   Drug: risedronate sodium;   Other: placebo
Sponsors:   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
Completed

Mon, 27 Jan 2003 12:00:00 EST

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Condition:   Osteoporosis, Postmenopausal
Intervention:   Drug: Ibandronate (SB743830HD)
Sponsor:   GlaxoSmithKline
Completed

Thu, 30 Nov 2006 12:00:00 EST

Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Condition:   Osteoporosis
Interventions:   Procedure: bone densitometry (DEXA);   Drug: alendronate or risedronate
Sponsors:   University of Alberta;   Alberta Heritage Foundation for Medical Research
Completed

Fri, 26 Aug 2005 12:00:00 EDT

Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy

Conditions:   Osteoporosis;   Muscular Dystrophy;   Cystic Fibrosis
Intervention:   Drug: Bisphosphonate treatment
Sponsors:   Gilles Boire;   Procter and Gamble
Completed

Thu, 20 Jun 2013 12:00:00 EDT

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

Condition:   Osteopenia
Interventions:   Drug: bisphosphonate therapy (risedronate);   Dietary Supplement: Vitamin D supplement;   Dietary Supplement: Calcium
Sponsors:   State University of New York - Upstate Medical University;   Genentech, Inc.
Terminated

Mon, 05 Sep 2005 12:00:00 EDT

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Conditions:   Esophageal Cancer;   Squamous Cell Carcinoma;   Adenocarcinoma
Interventions:   Drug: Alendronate;   Drug: Etidronate;   Drug: Ibandronate;   Drug: Risedronate;   Drug: Raloxifene
Sponsors:   Merck Sharp & Dohme Corp.;   World Health Information Science Consultants, LLC
Completed

Mon, 01 Mar 2010 12:00:00 EST

Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study

Condition:   Ankylosing Spondylitis
Intervention:   Drug: drug treatment
Sponsors:   University of Zurich;   Sanofi
Completed

Wed, 23 Dec 2009 12:00:00 EST

Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis

Condition:   Postmenopausal Osteoporosis
Intervention:   Other: Observation
Sponsors:   Sheffield Teaching Hospitals NHS Foundation Trust;   University of Sheffield
Completed

Mon, 01 Aug 2011 12:00:00 EDT

Reconnecting: Improving Interoception to Reduce Suicidal Ideation in the Military

Conditions:   Suicidal Ideation;   Interoception
Interventions:   Behavioral: RISE (Reconnecting to Internal Sensations and Experiences);   Behavioral: RISE (Reconnecting to Individual Strength and Energy)
Sponsors:   Miami University;   Auburn University
Recruiting

Wed, 25 Sep 2019 12:00:00 EDT

Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis

Condition:   Primary Osteoporosis
Interventions:   Drug: ibandronic acid 0.5mg;   Drug: RIS placebo;   Drug: 1.0mg ibandronic acid;   Drug: ibandronic acid placebo;   Drug: 2.5mg RIS;   Dietary Supplement: Calcium and Vitamine D3
Sponsor:   Chugai Pharmaceutical
Completed

Thu, 15 Mar 2007 12:00:00 EDT

Denosumab Safety Assessment in Multiple Observational Databases

Condition:   Osteoporosis
Interventions:   Drug: denosumab;   Drug: bisphosphonate
Sponsors:   Amgen;   Aarhus University Hospital;   Optum, Inc.;   University of Alabama at Birmingham
Active, not recruiting

Tue, 11 Aug 2015 12:00:00 EDT

Treating Idiopathic Inflammatory Myopathies Related Reduced Bone Mineral Density With Denosumab or Zoledronic Acid

Conditions:   Idiopathic Inflammatory Myopathies;   Osteoporosis, Osteopenia
Interventions:   Drug: Denosumab;   Drug: Zoledronic Acid
Sponsors:   Kwong Wah Hospital;   Tung Wah Group of Hospitals
Unknown status

Fri, 26 Jul 2019 12:00:00 EDT

Exome Sequencing for Atypical Femoral Fractures

Conditions:   Atypical Femoral Fractures;   Osteoporosis;   Bisphosphonate Therapy
Intervention:   Drug: Bisphosphonate
Sponsor:   Washington University School of Medicine
Completed

Thu, 07 Apr 2016 12:00:00 EDT

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Conditions:   Breast Cancer;   Osteoporosis
Interventions:   Dietary Supplement: calcium carbonate;   Dietary Supplement: calcium citrate;   Dietary Supplement: cholecalciferol;   Drug: alendronate sodium;   Drug: calcium gluconate;   Drug: risedronate sodium;   Other: laboratory biomarker analysis;   Procedure: dual x-ray absorptometry
Sponsors:   NCIC Clinical Trials Group;   National Cancer Institute (NCI);   North Central Cancer Treatment Group;   Southwest Oncology Group
Completed

Thu, 20 Jul 2006 12:00:00 EDT

Arimidex Bone Mass Index and Oral Bisphosphonates

Conditions:   Breast Cancer;   Bone Density
Intervention:  
Sponsor:   Hellenic Breast Surgeons Society
Completed

Wed, 17 Dec 2008 12:00:00 EST

Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use

Conditions:   Osteoporosis, With or Without Treatment;   Bisphosphonate Treatment;   Atypical Femur Fracture;   Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ);   Healthy Volunteers
Intervention:  
Sponsor:   University of Pennsylvania
Active, not recruiting

Tue, 11 Jun 2013 12:00:00 EDT

VERTOS-II. Percutaneous Vertebroplasty Versus Conservative Therapy

Conditions:   Osteoporosis;   Back Pain
Intervention:   Procedure: Vertebroplasty
Sponsors:   Clinical Research Office Imaging Division;   ZonMw: The Netherlands Organisation for Health Research and Development
Completed

Tue, 04 Oct 2005 12:00:00 EDT